• OVPR

    The Office of the Vice President for Research facilitates collaborative research opportunities, streamlines related policies and procedures, and acts as a unified voice for U of I research.

  • UIC OTM

    The Office of Technology Management at Chicago is responsible for managing the intellectual property generated by research and educational activities at the University.

  • UIUC OTM

    The Office of Technology Management at Urbana-Champaign is responsible for managing the intellectual property generated by research and educational activities at the University.

  • UIC Research Center

    The UIC Research Center supplies a fully-equipped infrastructure and access to University resources, internship programs, world-class talent, and custom-designed business development services.

  • UI Research Park

    Provides an ideal environment for starting a high-growth technology venture, with wet-chemistry labs, office space, an array of shared equipment, server co-location facilities, and conference rooms.

  • IllinoisVENTURES

    IllinoisVENTURES is a seed and early-stage technology investment firm focused on research-derived companies in information technologies, physical sciences and life sciences, with a particular emphasis on those deriving from research conducted at the University of Illinois and other regional research institutions and federal laboratories.

Innovations at the University of Illinois

"America Invents Act" Reforms Patent Law

Grand Opening Reception of New Littlefuse High Power Testing Facility (Video)

University of Illinois at Urbana-Champaign Announces Licensing Agreement with Sigma-Aldrich to Provide Membrane Scaffold Proteins for Nanodisc Technology to the Research Community

Recap: Share the Vision 2012 Technology Showcase
Syndicate content

To innovate is to translate knowledge and ideas into economic growth and social well being. The University of Illinois is a leader in conducting groundbreaking research that forms the foundation for meaningful innovation. Our discoveries have led to products and services that have a profound impact on human lives.

The University has embraced its role as an engine of innovation by incorporating economic development as a cornerstone in our mission of teaching, research and public service. One of the results has been the creation of a system of resources to work with both the campus community and corporate partners to facilitate the protection and transfer of intellectual property.

This web portal is an entryway to the University’s commercialization services and to the many opportunities for our community and external partners to engage with us.

Lawrence B. Schook

Vice President for Research

 

Featured Start-Up

Business Logic Corporation

Featured Technology

Tissue Factor (TF) Nanodisc

Featured Publication

A Handbook for Inventors & Innovators
Syndicate content
Syndicate content

Connect With Us

The mission of the University’s economic development units is to leverage University of Illinois technologies and intellectual properties to benefit society, to support the growth of the Illinois and U.S. economies, and to strengthen the University’s education and research programs.

Whether you’re a University researcher with a breakthrough innovation or an industry leader looking to cultivate exciting new discoveries and cutting-edge technologies, we will work closely with you to facilitate the transfer of intellectual property in ways that benefit society and build enduring connections.

 

Inventor's Handbook

A Handbook for Inventors and Innovators: Technology Transfer at the University of Illinois

An introduction to the University’s intellectual property policies, patenting and commercialization services, intellectual property fundamentals, and most importantly, to your role in the process of commercializing University innovations. Learn more.

Internal (Teachers, Students, Faculty)

The units reporting to the Vice President for Research comprise a system of resources the University has created to facilitate the protection and transfer of University intellectual property, and to help ensure that University innovations have maximum public impact. The services we provide range from protecting and licensing intellectual property to providing facilities, consultation, and funding for start-ups.

LEARN MORE ›

 

External (Businesses, Industry, Investors)

The University of Illinois is a world-class research institution boasting a respected and accomplished faculty, high national rankings, one of the nation’s largest medical schools, state-of-the-art facilities, and a history of groundbreaking research.

The University holds a portfolio of inventions and has licensed an array of start-ups that represent the breadth and depth of our research engine. Individually, each represents an exciting opportunity. Combined they represent an intellectual property portfolio that is second to none.

We invite corporate and industry partners to learn more about the University and the possibilities represented by our innovations. Some of the many ways to engage with us include licensing University intellectual properties, utilizing space in our research park, sponsoring faculty research, hiring faculty consultants, and investing in start-up companies.

LEARN MORE ›

 

Our Offices of Technology Management hold a portfolio of innovations that is both broad and deep, ranging from therapeutics to semiconductors, imaging technologies to nanotechnologies, and from software to new crop varieties.
View All Technologies ›

 

Latest Technologies

Matricellular Scaffold Modulators for Regeneration of Periodontal Tissues
Periodontal disease is one of the major reasons for tooth loss in the United States and may be associated with systemic effects, including heart disease and rheumatoid arthritis. Although tooth retention has greatly improved over the past few decades, a significant percentage of older Americans do not have functional dentitions and only 42.4% of the U.S.
Biomimetic 3D Scaffolds for Bone and Dental Pulp Tissue Regeneration
Loss of dental and craniofacial tissues due to disease, injury or genetic disorders negatively affects the quality of life of millions of Americans. Presently, the gold standard in clinical treatment for craniofacial bone defects is autografts and demineralized bone matrix (DBM). Autografts perform exceptionally well, but are known to induce donor site morbidity and DBMs poorly induce regeneration of lost tissue.
UIC Land Viewer Tool, a web-based geospatial land use tracking tool
There is an increasing need to assess past, present and future use of land.  
A Breast Cancer Vaccine using Grb10
Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted)and the fifth most common cause of cancer death. However, among women worldwide, breast cancer is by far the most common cause of cancer, both in incidence and death. In 2005, breast cancer caused 502,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths). An antigen (from antibody-generating) or immunogen is a molecule that sometimes stimulates an immune response.
Syndicate content

Search Technologies

Start-Ups

This diverse collection of companies represents a range of affiliations by which the industry can get involved in start-ups, either through investing, licensing University technology, renting space at one of our top-notch research parks, or through IllinoisVENTURES.

View All Start-Ups ›

Search Start-ups

On April 16, 2010 Forbes.com ran a story, “In Depth:10 Technology Incubators That are Changing the World.” The University of Illinois Research Park was included in the list based on its support of startup technology firms, peer community of large corporate operations, student employment in companies and the history of innovations coming from the University of Illinois.

Featured Start-ups

Radius

http://www.radiuspharm.com/

Radius focuses on the discovery and development of a new generation of drug therapies for osteoporosis and women’s health. The company’s first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future fractures and improving the quality of life.

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)

Obiter Research

http://www.obires.com

Obiter Research is a startup chemical research company which will produce fine chemicals, and use this as a training arena for students of the School of Chemical Sciences in the University of Illinois. The company will also perform limited contract synthesis.

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)

Fluensee, Inc

http://www.fluensee.com/

RFID-enabled solutions that improve the efficiency and effectiveness of tracking and managing physical assets.

Last updated on Jul 26, 2010 (Created on Jun 05, 2010)
print